Editing Abetalipoproteinemia (section)

== Prognosis ==
Prognosis can vary heavily based on the severity of the neurological dysfunction. If treatment is initiated early in disease the neurologic sequelae may be reversed and further deterioration can be prevented.<ref name="pmid8340987">{{Cite journal |vauthors=Rader DJ, Brewer HB |date=August 1993 |title=Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease |journal=JAMA |volume=270 |issue=7 |pages=865–9 |doi=10.1001/jama.1993.03510070087042 |pmid=8340987}}</ref> Long-term outlook is reasonably good for most people when diagnosed and treated early. A case study presented a female patient diagnosed at the age of 11. Despite the relatively late diagnosis, the patient married and at the age of 34, gave birth to a full-term healthy infant. Her medication included vitamin K 10&nbsp;mg twice a week, beta-carotene 40,000 IU daily, vitamin A 10,000 IU daily, vitamin E 400 IU daily, vitamins B6 and B12, calcium, magnesium and eye drops.<ref>{{Cite journal |vauthors=Zamel R, Khan R, Pollex RL, Hegele RA |date=July 2008 |title=Abetalipoproteinemia: two case reports and literature review |journal=Orphanet Journal of Rare Diseases |volume=3 |issue=1 |pages=19 |doi=10.1186/1750-1172-3-19 |pmc=2467409 |pmid=18611256 |doi-access=free}}</ref>

Prolonged vitamin deficiencies can further compromise health. Specifically, a prolonged vitamin E deficiency can lead to the development of limiting [[ataxia]] and [[Gait deviations|gait disturbances]]. Some individuals may develop [[retinopathy|retinal degeneration]] and blindness. If left untreated, the condition may lead to death.'<ref name="GARD" />